Drug
Olmesartan clinical trials
- studies test it
- 21
- open now
- 1
- in phase 3
- 5
- first study started
- 2005
Keep track of what changes. Save the olmesartan studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
18 studies that test it; most in 2005 (3)
| Year | Studies |
|---|---|
| 2005 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2018 | 1 |
| 2021 | 2 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 2
- Phase 3
- 5
- Phase 4
- 8
- No phase
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 15
EMS (2) · Seoul National University Bundang Hospital (1) · Autotelicbio (1) · Aristotle University Of Thessaloniki (1) · Daiichi Sankyo (1) · University of Vigo (1) · AHEPA University Hospital (1) · Institut für Pharmakologie und Präventive Medizin (1)
Often tested with
Tested in the same studies.
Amlodipine (6) · Olmesartan Medoxomil (3) · Hydrochlorothiazide (3) · Rosuvastatin (2) · Dapagliflozin (1) · Nebivolol (1) · OLM 40MG (1) · Chlorthalidone (1)
Studies
Open first, then newest update. How each study uses olmesartan is read from its arms, and is right about nine times in ten.
Testing it · 21
- Multi-Omics to Predict the Blood Pressure Response to AntihypertensivesRecruitingPhase 4Radboud University Medical CenterNCT05917275Written as Olmesartan
- Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension ControlWithdrawnPhase 3EMSNCT02493322Written as Olmesartan 20mg + hydrochlorothiazide 12,5mg
- Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension ControlWithdrawnPhase 3EMSNCT02483936Written as Olmesartan 40mg + Hydrochlorothiazide 12,5mg
- Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and HypertensionCompletedPhase 4Seoul National University Bundang HospitalNCT05189015Written as Olmesartan
- Clinical Trial to Evaluate Pharmacokinetic Interaction of ATB-1011 and ATB-1012 in Healthy Adult VolunteersCompletedPhase 1AutotelicbioNCT04856969Written as Olmesartan
- Effect of Olmesartan and Nebivolol on Ambulatory Blood Pressure and Arterial Stiffness in Acute Stage of Ischemic StrokeCompletedPhase 2Aristotle University Of ThessalonikiNCT03655964Written as Olmesartan
- Effect of olmesaRtan on Walking distancE and quaLIty of lifE in Peripheral Artery Disease Patients With Hypertension Treated For Intermittent Claudication (RELIEF)TerminatedPhase 4Yonsei UniversityNCT02373462Written as Olmesartan
- Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in HypertensionCompletedPhase 3Daiichi SankyoNCT00902538Written as Olmesartan 40mg-Amlodipine 10mg-Hydrochlorothiazide 12.5mg
- Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk AssessmentCompletedPhase 4University of VigoNCT00741585Written as Any antihypertensive medication alone or in combination
- Use of Impedance Cardiography and Applanation Tonometry for Prediction of the Antihypertensive Effect of Two DrugsCompletedNot applicableAHEPA University HospitalNCT03560804Written as Olmesartan
- Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mgCompletedPhase 4Institut für Pharmakologie und Präventive MedizinNCT01611077Written as Olmesartan/amlodipine
- Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose TissueStatus unknownPhase 4Kurume UniversityNCT02996916Written as Olmesartan
- The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic DiseaseStatus unknownPhase 2Samsung Medical CenterNCT02516826Written as Olmesartan
- Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure StudyWithdrawnPhase 4Monash UniversityNCT01089452Written as Olmesartan/amlodipine
- Effects of Antihypertensive Drugs in Patients With Hypertension and Obstructive Sleep Apnea (OSA)CompletedNot applicableKyoto University, Graduate School of MedicineNCT01028534Written as Olmesartan and Azelnidipine
- Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose IntoleranceCompletedNot applicableEmory UniversityNCT00122447Written as Olmesartan
- Investigation of Pharmacokinetic Interaction Between Rosuvastatin and Olmesartan in Healthy Male VolunteersCompletedPhase 1Severance HospitalNCT01831479Written as Olmesartan
- Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial FibrillationCompletedPhase 3Atrial Fibrillation NetworkNCT00098137Written as Olmesartan
- Renin Profiling in Selection of Initial Antihypertensive DrugCompletedNot applicableThe Louis & Rachel Rudin FoundationNCT00834600Written as olmesartan, hydrochlorothiazide, amlodipine
- Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential HypertensionCompletedPhase 3TakedaNCT00696241Written as Azilsartan medoxomil and olmesartan
See all 21 studies that test olmesartan →
Given in every arm · 2 — olmesartan is usual care beside what is tested
- Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)CompletedPhase 2Alnylam PharmaceuticalsNCT05103332Written as Olmesartan
- Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?TerminatedPhase 3University of British ColumbiaNCT04606563Written as Olmesartan
As the comparator · 11 — what is tested is compared with olmesartan
- Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX TabCompletedPhase 4Daewoong Pharmaceutical Co. LTD.NCT04120753Written as Olmesartan 20 mg/Amlodipine 5 mg
- A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With HypertensionCompletedPhase 2Novartis PharmaceuticalsNCT01870739Written as olmesartan
- Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential HypertensionCompletedPhase 3Novartis PharmaceuticalsNCT01785472Written as Olmesartan
- Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With HypertensionCompletedPhase 2Novartis PharmaceuticalsNCT01692301Written as Olmesartan
- Efficacy and Safety of LCZ696 Compared to Olmesartan in Essential Hypertensive Patients Not Responsive to OlmesartanCompletedPhase 3Novartis PharmaceuticalsNCT01876368Written as Olmesartan
- Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential HypertensionCompletedPhase 3Novartis PharmaceuticalsNCT01615198Written as Olmesartan
- Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential HypertensionCompletedPhase 3Novartis PharmaceuticalsNCT01599104Written as Olmesartan
- Clinical Study for Patients With Hypertension Associated With DyslipidemiaCompletedPhase 3Daewoong Pharmaceutical Co. LTD.NCT01764295Written as Olmesartan
- An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.CompletedPhase 3TakedaNCT00696436Written as Olmesartan
- Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate HypertensionCompletedPhase 2TakedaNCT00362115Written as Olmesartan
- Efficacy and Safety of Azilsartan in Subjects With Essential HypertensionCompletedPhase 2TakedaNCT00759551Written as Olmesartan
Codes
What other systems call olmesartan · ClinicalTrials.gg INT004387
- MeSH (NLM) C437965olmesartanConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 8W1IQP3U10OLMESARTANConfirmed FDA, NLM, Wikidata
- RxNorm 321064Confirmed FDA, Wikidata
- Wikidata Q421156olmesartanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66253OlmesartanOne source FDA
- DrugBank DB00275One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C437965 | olmesartan | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 8W1IQP3U10 | OLMESARTAN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 321064 | — | Confirmed FDA, Wikidata |
| Wikidata | Q421156 | olmesartan | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66253 | Olmesartan | One source FDA |
| DrugBank | DB00275 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.